Articles

Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. More

These blue-chip stocks were the winning plays in the first quarter, but Dow denizens need to prove they can keep the winning streak going. More

The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates. More

Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time. More

The application of AI in biology holds the potential to unlock enormous economic value for one simple reason – data. More

Market crashes are just a part of investing whose impact you can minimize by buying defensive stocks that can shine no matter the conditions. More

BOWL stock results show that Bowlero missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024. More

Subscriber Sign in